Converging Focused Ultrasound and Liquid Biopsy for Glioma Management: Next Steps.

Authors

Connor J Liu, Graeme F Woodworth, Chetan Bettegowda

Published in

Hematology/oncology clinics of North America. Oct 09, 2026. Epub Oct 09, 2026.

Abstract

Gliomas represent one of the most formidable challenges in oncology due to their diffuse infiltrative growth in the brain, marked molecular heterogeneity, immune evasion, and the restrictive nature of the blood-brain barrier (BBB), which collectively undermine effective therapy. This review examines the rationale, current evidence, and translational hurdles for integrating focused ultrasound (FUS)-mediated BBB opening and liquid biopsy strategies in gliomas. In this context, FUS may serve as both a therapeutic adjunct and a tool to improve biomarker accessibility and imaging integration, while artificial intelligence-driven analytics synthesize complex datasets into actionable insights.

PMID:
42855393
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.